Literature DB >> 12615429

Adverse medical events in British service personnel following anthrax vaccination.

Joanne E Enstone1, Martin C J Wale, Jonathan S Nguyen-Van-Tam, James C G Pearson.   

Abstract

The safety of the UK anthrax vaccine in British service personnel was evaluated by a retrospective cohort study of randomly selected personnel from five Royal Air Force bases by investigating adverse medical events and consultation rates for a period before and after vaccination. Vaccination acceptance rate varied from 27 to 89% (P=0.0001). In the vaccinated cohort 11.1% (n=368) reported side-effects. The number of consultations in the year prior to vaccination (P=0.04) and RAF base (P=0.0085) were associated with side-effects. Only the RAF base remained a statistically significant factor (P=0.007) after adjusting for other factors. The anthrax vaccine resulted in mild side-effects in 11%, and no serious side-effects were observed. Acceptors of vaccine did not have significantly more medical consultations following vaccination than their unvaccinated counterparts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615429     DOI: 10.1016/s0264-410x(02)00690-4

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

Review 1.  Health concerns in UK Armed Forces personnel.

Authors:  Dominic Murphy; Neil Greenberg; Duncan Bland
Journal:  J R Soc Med       Date:  2009-04       Impact factor: 5.344

2.  Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity.

Authors:  Demetrios N Kyriacou; Debra Dobrez; Jorge P Parada; Justin M Steinberg; Adam Kahn; Charles L Bennett; Brian P Schmitt
Journal:  Biosecur Bioterror       Date:  2012-07-30

Review 3.  Anthrax lethal toxin and the induction of CD4 T cell immunity.

Authors:  Stephanie Ascough; Rebecca J Ingram; Daniel M Altmann
Journal:  Toxins (Basel)       Date:  2012-10-19       Impact factor: 4.546

4.  Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity.

Authors:  Stephanie Ascough; Rebecca J Ingram; Karen K Chu; Catherine J Reynolds; Julie A Musson; Mehmet Doganay; Gökhan Metan; Yusuf Ozkul; Les Baillie; Shiranee Sriskandan; Stephen J Moore; Theresa B Gallagher; Hugh Dyson; E Diane Williamson; John H Robinson; Bernard Maillere; Rosemary J Boyton; Daniel M Altmann
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

5.  Identification of peptide sequences as a measure of Anthrax vaccine stability during storage.

Authors:  Gail Whiting; Jun X Wheeler; Sjoerd Rijpkema
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.